Edited by Dmitry I. Gabrilovich, MD, PhD; Jennifer Guerriero, PhD; and Judith A. Varner, PhD
This JITC series aims to advance the biological understanding of myeloid cell biology within the tumor and strategies to modulate the function and activity of myeloid cells for anti-cancer therapy. Building upon the enthusiasm of the “Targeting Myeloid Cells in Immuno-Oncology” pre-conference workshop jointly sponsored by the Society for Immunotherapy of Cancer (SITC) and the Myeloid Network at the 2023 SITC Annual Meeting, this series will be comprised of viewpoint opinion commentaries on controversial topics in the field along with two review articles.
View the two review articles that have published in the series below and check back throughout early 2026 for additional content.